Genocea Biosciences reported $270K in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Agenus AGEN:US $ 20.93M 5.01M
Baxter International BAX:US $ 3746M 39M
Bluebird Bio BLUE:US $ 1.52M 0.43M
Cytokinetics CYTK:US $ 88.97M 87.82M
Genocea Biosciences GNCA:US $ 0.27M 0.27M
Glaxosmithkline GSK:US $ 6929M 2851M
Infinity Pharmaceuticals INFI:US $ 0.69M 0.03M
Merk MRK:US $ 14593M 1308M
Mirati Therapeutics MRTX:US $ 5.36M 4.65M
Moderna Inc MRNA:US 4.75B 1.32B
Novavax NVAX:US $ 185.92M 518.05M
Pfizer PFE:US $ 27742M 2081M
Prothena PRTA:US 1.31M 159K